Cardiovascular preventive recommendations. PAPPS 2020 update
Por:
Orozco-Beltrán D., Brotons Cuixart C., Alemán Sánchez J.J., Banegas Banegas J.R., Cebrián-Cuenca A.M., Gil Guillen V.F., Martín Rioboó E., Navarro Pérez J.
Publicada:
1 ene 2020
Resumen:
The recommendations of the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The following sections are included: Epidemiological review, where the current morbidity and mortality of CVD in Spain and its evolution as well as the main risk factors are described; Cardiovascular (CV) risk tables and recommendations for the calculation of CV risk; Main risk factors such as arterial hypertension, dyslipidemia and diabetes mellitus, describing the method for their diagnosis, therapeutic objectives and recommendations for lifestyle measures and pharmacological treatment; Indications for antiplatelet therapy, and recommendations for screening of atrial fibrillation. The quality of testing and the strength of the recommendation are included in the main recommendations. © 2020 The Authors
Filiaciones:
Orozco-Beltrán D.:
Unidad de Investigación CS Cabo Huertas, Departamento San Juan de Alicante, Departamento de Medicina Clínica. Universidad Miguel Hernández, Spain
Brotons Cuixart C.:
Equipo de Atención Primaria Sardenya, Barcelona, Spain
Alemán Sánchez J.J.:
Dirección General de Salud Pública, Servicio Canario de la Salud, Spain
Banegas Banegas J.R.:
Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain
Cebrián-Cuenca A.M.:
Centro de Salud Cartagena Casco Antiguo, Cartagena, Murcia, Spain
Gil Guillen V.F.:
Departamento de Medicina Clínica, Universidad Miguel Hernández, Spain
Martín Rioboó E.:
UGC Poniente en Córdoba Distrito Sanitario Córdoba Guadalquivir, Córdoba, Spain
Navarro Pérez J.:
Hospital Clínico Universitario, Departamento de Medicina, Universidad de Valencia, Instituto de Investigación INCLIVA, Valencia, Spain
All Open Access, Gold
|